decualini, chloride - leitarniðurstöður

Evrópusambandið - íslenska - EMA (European Medicines Agency)

inaqovi

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - kyrningahvítblæði, mergbólga - Æxlishemjandi lyf - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

dacogen

janssen-cilag international n.v. - decitabin - kyrningahvítblæði, mergbólga - Æxlishemjandi lyf - meðferð fullorðinn sjúklinga með nýlega greind de new eða efri bráð merg hvítblæði (aml), samkvæmt heiminum heilsu fyrirtækisins (sem) flokkun, sem eru ekki mönnum fyrir standard framkalla lyfjameðferð.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

venclyxto

abbvie deutschland gmbh co. kg - venetoclax - kyrningahvítblæði, eitilfrumnafæð, langvarandi, b-frumur - Æxlishemjandi lyf - venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. venclyxto in combination with rituximab is indicated for the treatment of adult patients with cll who have received at least one prior therapy. venclyxto monotherapy is indicated for the treatment of cll:- in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor, or- in the absence of 17p deletion or tp53 mutation in adult patients who have failed both chemoimmunotherapy and a b-cell receptor pathway inhibitor. venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

episalvan

amryt ag - betulae cortex - wounds and injuries; wound healing - undirbúningur til meðferðar á sár og sár - meðferð á þykktum í þykktum hjá fullorðnum. sjá kafla 4. 4 og 5. 1 í upplýsingum um vörur með tilliti til tegundar sárs sem rannsakað er.